BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33166734)

  • 1. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
    Shi D; Xu Y; Du X; Chen X; Zhang X; Lou J; Li M; Zhuo J
    Mol Med Rep; 2015 Dec; 12(6):8223-8. PubMed ID: 26496980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evidence for the pharmacological actions of naringin: a review.
    Bharti S; Rani N; Krishnamurthy B; Arya DS
    Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlights in Resistance Mechanism Pathways for Combination Therapy.
    Delou JMA; Souza ASO; Souza LCM; Borges HL
    Cells; 2019 Aug; 8(9):. PubMed ID: 31480389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Potential of Naringenin, Biosynthesis, Molecular Target, and Structural Perspectives.
    Prakash O; Singh R; Singh N; Usmani S; Arif M; Kumar R; Ved A
    Mini Rev Med Chem; 2022; 22(5):758-769. PubMed ID: 34517796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of colorectal carcinogenesis by naringin.
    Ansari B; Aschner M; Hussain Y; Efferth T; Khan H
    Phytomedicine; 2022 Feb; 96():153897. PubMed ID: 35026507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
    Den Hartogh DJ; Tsiani E
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30871083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
    Nyane NA; Tlaila TB; Malefane TG; Ndwandwe DE; Owira PMO
    Eur J Pharmacol; 2017 May; 803():103-111. PubMed ID: 28322845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Pharmacological and Analytical Aspects of Naringenin.
    Patel K; Singh GK; Patel DK
    Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating oxidative stress disorders with citrus flavonoid: Naringenin.
    Zaidun NH; Thent ZC; Latiff AA
    Life Sci; 2018 Sep; 208():111-122. PubMed ID: 30021118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities.
    Stabrauskiene J; Kopustinskiene DM; Lazauskas R; Bernatoniene J
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise.
    Rani N; Bharti S; Krishnamurthy B; Bhatia J; Sharma C; Kamal MA; Ojha S; Arya DS
    Curr Pharm Des; 2016; 22(28):4341-59. PubMed ID: 27238365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.